Advertisement
Singapore markets close in 5 hours 55 minutes
  • Straits Times Index

    3,294.70
    +21.98 (+0.67%)
     
  • Nikkei

    38,329.39
    +777.23 (+2.07%)
     
  • Hang Seng

    17,142.04
    +313.11 (+1.86%)
     
  • FTSE 100

    8,044.81
    +20.94 (+0.26%)
     
  • Bitcoin USD

    66,614.47
    -147.13 (-0.22%)
     
  • CMC Crypto 200

    1,434.28
    +19.52 (+1.38%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • Dow

    38,503.69
    +263.71 (+0.69%)
     
  • Nasdaq

    15,696.64
    +245.33 (+1.59%)
     
  • Gold

    2,334.40
    -7.70 (-0.33%)
     
  • Crude Oil

    83.37
    +0.01 (+0.01%)
     
  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     
  • FTSE Bursa Malaysia

    1,567.52
    +5.88 (+0.38%)
     
  • Jakarta Composite Index

    7,174.83
    +64.01 (+0.90%)
     
  • PSE Index

    6,577.48
    +70.68 (+1.09%)
     

Up 40% in 1 Day, Is Novavax Stock a Buy Now?

Up 40% in 1 Day, Is Novavax Stock a Buy Now?

On May 9, Novavax (NASDAQ: NVAX) shareholders got a much-needed reprieve from the stock's downward trajectory over the last year. Novavax's decline is a regrettable one. Its coronavirus vaccine candidate ran into regulatory issues during clinical development, and arrived on the market much later than those of competitors like Pfizer and Moderna.